EDAP Reports 2019 Third Quarter and Nine Months Results
(WorldNews France)

67.8% growth in HIFU revenue through the nine month period ended September 30 over the comparable period in 2018 48.2% Gross margin for the nine month period ended September 30 compared to 42.3% for the comparable period in 2018 Fourth consecutive quarter of profitability Continued to drive US sales strategy towards reference centers with sale of Focal One to Mayo Clinic Company to host a conference call on November 14, 2019 at 8:30am EST LYON, France, November 13, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (`the Company`), the global leader in therapeutic ultrasound, announced today financial results for the third quarter and nine months of 2019 and provided an update on strategic and operational...